Live Breaking News & Updates on Exacis biotherapeutics

Stay updated with breaking news from Exacis biotherapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Global Induced Pluripotent Stem Cell (iPSC) Industry

Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The

Hamburg , Germany , United-states , Cambridge , Cambridgeshire , United-kingdom , Kobe , Hyogo , Japan , Taiwan , Dublin , Ireland

Eterna Therapeutics Appoints Megan Yung as Chief Strategy

CAMBRIDGE, Mass., May 24, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science company...

Cambridge , Cambridgeshire , United-kingdom , Exacis-biotherapeutics , Quinn-emanuel-urquhart-sullivan , Foley-lardner , Matt-angel , Megan-yung , Exchange-commission , Securities-exchange , Eterna-therapeutics-inc , Nasdaq

Eterna Therapeutics Appoints Megan Yung as Chief Strategy Officer, General Counsel

Eterna Therapeutics Appoints Megan Yung as Chief Strategy Officer, General Counsel
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , Quinn-emanuel-urquhart-sullivan , Exacis-biotherapeutics , Foley-lardner , Matt-angel , Megan-yung , Nasdaq , Eterna-therapeutics-inc , George-washington-university-law-school , Exchange-commission

Global CAR T Cell Therapy Competitive Landscape Report 2023: Insights About 250+ Companies and 500+

DUBLIN--(BUSINESS WIRE)--The "CAR T - Cell Therapy - Competitive landscape, 2023" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about 250+ companies and 500+ drugs in CAR T - Cell Therapy Competitive landscape. It covers the therapeutics assessment by product...

United-states , Wugen , Zhejiang , China , Huadong , Guangdong , American , Exacis-biotherapeutics , Liminatus-pharma , Gracell-bio , Neukio-biotherapeutics , Miltenyi-biotec

Eterna Therapeutics Acquires Exacis' Allogeneic Immuno-Oncology Platform

Eterna says it is well-positioned to develop more effective, targeted, and highly differentiated medicines to treat cancer.

Matt-angel , Gregory-fiore , Exacis-biotherapeutics , Eterna-therapeutics , With-exaci ,

Eterna Therapeutics (ERNA) Acquires Allogeneic Immuno-Oncology Platform from Exacis Biotherapeutics

Eterna Therapeutics (ERNA) Acquires Allogeneic Immuno-Oncology Platform from Exacis Biotherapeutics
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Dimitrios-goundis , Gregory-fiore , Exacis-biotherapeutics , Matt-angel , Maxivax-sa-eterna , Head-of-research , Exchange-commission , Medicines-company , Securities-exchange , Nasdaq , Novartis , Eterna-therapeutics-inc

Eterna Therapeutics Acquires Allogeneic Immuno-Oncology Platform from Exacis Biotherapeutics

Eterna Therapeutics Acquires Allogeneic Immuno-Oncology Platform from Exacis Biotherapeutics
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , Dimitrios-goundis , Exacis-biotherapeutics , Maxivax-sa-eterna , Matt-angel , Gregory-fiore , Eterna-therapeutics-inc , Medicines-company , Exchange-commission , Novartis

Global Induced Pluripotent Stem Cell (iPSC) Industry Report 2023: Rapidly Growing Number of Studies Bodes Well for Sector

/PRNewswire/ -- The "Global Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, and Forecasts, 2023" report has been added to...

Germany , Japan , Hamburg , Tokyo , United-kingdom , Cambridge , Cambridgeshire , Kyoto , Dublin , Ireland , Kobe , Hyogo

Eterna Therapeutics Appoints Matt Angel, Ph.D. as Chief Executive Officer and President

Eterna Therapeutics Appoints Matt Angel, Ph.D. as Chief Executive Officer and President
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , Matt-angel , Charles-cherington , Eterna-therapeuticseterna , Exacis-biotherapeutics , Company-board-of-directors , Massachusetts-institute-of-technology , Princeton-university , Factor-bioscience-inc , Nasdaq

In a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews Dr. Matt Angel, CEO Eterna Therapeutics

NEW YORK, NY / ACCESSWIRE / December 20, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued

Eterna , Niedersachsen , Germany , Matt-angel , Toni-loudenbeck , Exacis-biotherapeutics , Mark-roberts , Massachusetts-institute-of-technology , Factor-bioscience-inc , Traders-news-source , Eterna-therapeutics , News-source